REQUEST A DEMO
Total
USD $0.00
Search more companies

Ips Dartesalud S.A.S. Sigla Ips Dartesalud S.A.S. (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Pharmacies and Drug Stores | Diagnostic Imaging Centers | Other Ambulatory Health Care Services
Full name: Ips Dartesalud S.A.S. Sigla Ips Dartesalud S.A.S. Profile Updated: September 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Ips Dartesalud S.A.S. Sigla Ips Dartesalud S.A.S. is an enterprise in Colombia, with the main office in Galapa. It operates in the Ambulatory Health Care Services sector. The company was established on March 07, 2016. There was a net sales revenue increase of 20.15% reported in Ips Dartesalud S.A.S. Sigla Ips Dartesalud S.A.S.’s latest financial highlights for 2023. There was a total growth of 56.58% in Ips Dartesalud S.A.S. Sigla Ips Dartesalud S.A.S.’s total assets over the same period. The net profit margin of Ips Dartesalud S.A.S. Sigla Ips Dartesalud S.A.S. increased by 1.93% in 2023.

Headquarters
Cl 12 No 15 - 63
Galapa; Atlantico;

Contact Details: Purchase the Ips Dartesalud S.A.S. Sigla Ips Dartesalud S.A.S. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Ips Dartesalud S.A.S. Sigla Ips Dartesalud S.A.S. report to view the information.
Incorporation Date:
March 07, 2016
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Ips Dartesalud S.A.S. Sigla Ips Dartesalud S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
20.15%
Total operating revenue
20.15%
Operating profit (EBIT)
55.64%
EBITDA
43.32%
Net Profit (Loss) for the Period
50.19%
Total assets
56.58%
Total equity
59.5%
Operating Profit Margin (ROS)
3.87%
Net Profit Margin
1.93%
Return on Equity (ROE)
-2.09%
Quick Ratio
0.42%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?